San Diego's Scripps Translational Science Institute will conduct the first study to assess whether people taking genetic tests will change their behavior, says this article in SciAm. Scripps will offer its 10,000 employees, family members, and friends of the nonprofit Scripps Health system Navigenics' genetic test, and changes in behavior will be assessed over a 20-year period. The study will be led by Eric Topol, director at Scripps.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.